These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34045097)

  • 1. PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
    Laguno M; Ugarte A; Martinez-Rebollar M; Sobrino Y; Font G; de Lazzari E; de la Mora L; Torres B; Chivite I; Riera J; Ambrosioni J; Inciarte A; González-Cordón A; Rojas J; Cordón E; Blanco JL; Martínez E; Mallolas J
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 May; ():. PubMed ID: 34045097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP program experience in a hospital HIV unit. Description of baseline user profile and identification of opportunities for improvement.
    Laguno M; Ugarte A; Martinez-Rebollar M; Sobrino Y; Font G; de Lazzari E; de la Mora L; Torres B; Chivite I; Riera J; Ambrosioni J; Inciarte A; Gonzalez-Cordon A; Rojas J; Cordon E; Blanco JL; Martinez E; Mallolas J
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Jan; 41(1):24-28. PubMed ID: 35810144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience.
    Fernández Piñeiro N; Ayerdi Aguirrebengoa O; Orviz García E; González Pérez C; Vera García M; Puerta López T; Rodríguez Martín C; Lejarraga Cañas C; Perez García J; Baza Caraciolo B; González Polo M; Alcudia Pérez F; Ruiz Fernández M; Jerez Zamora N; Morales Irala D; López Centeno B; Alioto D; Martínez Sesmero JM; Estrada Pérez V; Benítez Gimenez MT; Romero Guerrero JD
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 Jun; ():. PubMed ID: 38897909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years' Experience.
    Ugarte A; de la Mora L; García D; Martínez-Rebollar M; de Lazzari E; Torres B; Inciarte A; Ambrosioni J; Chivite I; Solbes E; de Loredo N; Del Carlo GF; González-Cordón A; Blanco JL; Martínez E; Mallolas J; Laguno M
    Infect Dis Ther; 2023 Feb; 12(2):425-442. PubMed ID: 36520330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexually Transmitted Infections: Experience in a Multidisciplinary Clinic in a Tertiary Hospital (2010-2013).
    Moreno-Ribera N; Fuertes-de Vega I; Blanco-Arévalo JL; Bosch-Mestres J; González-Cordón A; Estrach-Panella T; García-de Olalla P; Alsina-Gibert M
    Actas Dermosifiliogr; 2016 Apr; 107(3):235-41. PubMed ID: 26708458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montréal, Canada (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Trottier C; Vaziri M; Thomas R; Maheu-Giroux M
    Drug Alcohol Depend; 2021 Sep; 226():108875. PubMed ID: 34218004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation models and access to HIV pre-exposure prophylaxis in Spain.
    Mir JF; Mazarío MF; Coll P
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 May; 38(5):234-237. PubMed ID: 31279586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual behavior and drug use impact in gay, bisexual, and other men who have sex with men.
    García-Pérez JN; Cañas-Ruano E; Navarro J; Raventós B; López L; Broto C; Arando M; Barberá MJ; Descalzo V; Suanzes P; Burgos J; Curran A; Falcó V
    Med Clin (Barc); 2022 Dec; 159(12):563-568. PubMed ID: 35725636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To whom is HIV pre-exposure prophylaxis proposed?
    Ayerdi-Aguirrebengoa O; Vera-García M; Puerta-López T; Raposo-Utrilla M; Rodríguez-Martín C; Del Romero-Guerrero J
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):299-302. PubMed ID: 27445176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement.
    Ahaus P; Schmidt AJ; Skaletz-Rorowski A; Uhrmacher M; Serova K; Kayser A; Wach J; Nambiar S; Brockmeyer NH; Potthoff A
    J Infect Public Health; 2022 Sep; 15(9):955-960. PubMed ID: 35926293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life cohort experience after implementing HIV pre-exposure prophylaxis for one year in northwest Spain.
    Pérez-González A; Represa M; Coll P; Potel C; Rodríguez-Rivero S; Flores EV; Vázquez-Estévez C; Ocampo A; Pousada G; Poveda E
    Front Public Health; 2022; 10():1005622. PubMed ID: 36388349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users.
    Ayerdi O; Orviz E; Valls Carbó A; Fernández Piñeiro N; Vera García M; Puerta López T; Ballesteros Martín J; Rodríguez Martín C; Baza Caraciolo B; Lejarraga Cañas C; Pérez-García JA; Carrió D; García Lotero M; Ferreras Forcada M; González Polo M; Raposo Utrilla M; Delgado-Iribarren A; Del Romero-Guerrero J; Estrada Pérez V
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 Dec; 42(10):570-576. PubMed ID: 38492988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Tabatabavakili S; Aleyadeh W; Cerrocchi O; Janssen HLA; Hansen BE; Bogoch II; Feld JJ;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):674-681. PubMed ID: 33737225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants.
    O'Halloran C; Rice B; White E; Desai M; Dunn DT; McCormack S; Sullivan AK; White D; McOwan A; Gafos M
    Int J Drug Policy; 2019 Dec; 74():246-254. PubMed ID: 31739177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of biomedical interventions in HIV prevention: Pre-exposure Prophylaxis (PrEP)].
    Zioga EAM; Arias-de la Torre J; Patera E; Borjabad B; Macorigh L; Ferrer L
    Semergen; 2020 Apr; 46(3):202-207. PubMed ID: 31395477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Immunodeficiency Virus Preexposure Prophylaxis Knowledge, Attitudes and Perceptions of Sexual Health Risk in an Age of Sexually Transmitted Infection Antimicrobial Resistance.
    Lorenc A; Nicholls J; Kesten JM; Macgregor L; Speare N; Harryman L; Turner KME; Horner P; Horwood J
    Sex Transm Dis; 2021 Sep; 48(9):685-692. PubMed ID: 33534406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.